Low seroconversion rates in CAPD patients compared to hemodialysis patients: potential advantages for transplant candidates.
D005260:Female; D006526:Hepatitis C / Q000097:blood* / Q000209:etiology* / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000097:blood* / Q000276:immunology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications* / Q000628:therapy; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D012698:Serologic Tests; D013997:Time Factors
D018937:Hepatitis C Antibodies